1.Prevention and Treatment of Asthma by Traditional Chinese Medicine Regulating PI3K/Akt Signaling Pathway: A Review
Yasheng DENG ; Yanping FAN ; Wenyue LI ; Yonghui LIU ; Zhaobing NI ; Jinjiang XU ; Haobin CHEN ; Qiuye WU ; Jiang LIN
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):262-275
Asthma is a chronic inflammatory respiratory disease involving multiple cells and cellular components, characterized by recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, significantly impacting patients' quality of life. The phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt) signaling pathway, as a crucial hub in intracellular signaling, is widely involved in the regulation of cell growth, proliferation, survival, metabolism, and a series of pathophysiological processes. Its regulatory role in the pathological progression of asthma is particularly significant, specifically in promoting airway inflammation, mediating epithelial mesenchymal transition, accelerating airway remodeling, regulating cell autophagy, inducing mucus hypersecretion, and influencing immune response balance. This study analyzed potential molecular targets of the PI3K/Akt pathway, including activators such as cysteine proteinase inhibitor 1(CST1), found in inflammatory zone 1(FIZZ1) and free fatty acid receptor 1(FFAR1), and inhibitors such as human β-defensin-3(hBD-3), disintegrins, metalloproteinase 33(ADAM33) and interleukin-27(IL-27), and initially revealed the potential molecular mechanisms of traditional Chinese medicine(TCM) in asthma intervention. Based on this, the authors systematically summarized the efficacy and specific mechanisms of TCM monomers, compounds, and external treatments for asthma by regulating the PI3K/Akt signaling pathway through literature review and analysis, aiming at establishing a robust foundation for the wide application and advanced development of TCM in asthma treatment, offering innovative insights for clinical research and drug development of asthma.
2.Prevention and Treatment of Asthma by Traditional Chinese Medicine Regulating PI3K/Akt Signaling Pathway: A Review
Yasheng DENG ; Yanping FAN ; Wenyue LI ; Yonghui LIU ; Zhaobing NI ; Jinjiang XU ; Haobin CHEN ; Qiuye WU ; Jiang LIN
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):262-275
Asthma is a chronic inflammatory respiratory disease involving multiple cells and cellular components, characterized by recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, significantly impacting patients' quality of life. The phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt) signaling pathway, as a crucial hub in intracellular signaling, is widely involved in the regulation of cell growth, proliferation, survival, metabolism, and a series of pathophysiological processes. Its regulatory role in the pathological progression of asthma is particularly significant, specifically in promoting airway inflammation, mediating epithelial mesenchymal transition, accelerating airway remodeling, regulating cell autophagy, inducing mucus hypersecretion, and influencing immune response balance. This study analyzed potential molecular targets of the PI3K/Akt pathway, including activators such as cysteine proteinase inhibitor 1(CST1), found in inflammatory zone 1(FIZZ1) and free fatty acid receptor 1(FFAR1), and inhibitors such as human β-defensin-3(hBD-3), disintegrins, metalloproteinase 33(ADAM33) and interleukin-27(IL-27), and initially revealed the potential molecular mechanisms of traditional Chinese medicine(TCM) in asthma intervention. Based on this, the authors systematically summarized the efficacy and specific mechanisms of TCM monomers, compounds, and external treatments for asthma by regulating the PI3K/Akt signaling pathway through literature review and analysis, aiming at establishing a robust foundation for the wide application and advanced development of TCM in asthma treatment, offering innovative insights for clinical research and drug development of asthma.
3.Study on the regulatory effects of Buqi tongqiao formula on intestinal flora and immune balance in IgA nephropathy rats
Jinjiang XU ; Man ZHANG ; Qiuye WU ; Xiongbin GUI
China Pharmacy 2025;36(20):2512-2518
OBJECTIVE To explore the regulatory effects of Buqi tongqiao formula on intestinal flora and immune balance in immunoglobulin A nephropathy (IgAN) rats based on the theory of “treating different diseases with the same therapy”. METHODS Male SD rats were randomly assigned to the Normal group and the modeling group. IgAN rat models were established in the modeling group by intragastric administration of bovine serum albumin, subcutaneous injection of carbon tetrachloride and castor oil mixture, and tail vein injection of lipopolysaccharide. Successfully modeled rats were then randomly divided into the model group (Model group), Buqi tongqiao formula low-dose group (BQTQ-L group), Buqi tongqiao formula high-dose group (BQTQ- H group), and positive control group (BZP group), with 15 rats in each group. BZP group received intragastric administration of benazepril hydrochloride (10 mg/kg), while BQTQ-L and BQTQ-H groups were given Buqi tongqiao formula at doses of 9.81 and 19.62 g/kg (calculated as raw herb weight), respectively. The Normal group and the Model group received an equal volume of normal saline intragastrically, once a day, for 8 consecutive weeks. The 24-hour urinary total protein (24 h UTP) contents were measured at weeks 8, 10, 12, 14 and 16 of the experiment. After the last administration, serum creatinine (Scr) and blood urea nitrogen (BUN) contents were detected. Renal histopathological changes and glomerular IgA immune complex deposition were examined. Additionally, alterations in gut microbiota composition, the proportions of peripheral T helper cell 17 (Th17) and regulatory T cell (Treg), as well as the ratio of Th17 and Treg (Th17/Treg), were analyzed across all groups. RESULTS Compared with the Model group, rats in both BQTQ-L and BQTQ-H groups showed alleviated mesangial cell hyperplasia, reduced matrix expansion, and decreased IgA immune complex deposition in the glomeruli. The 24 h UTP contents (at weeks 14 and 16 in the BQTQ-L group; at weeks 12, 14 and 16 in the BQTQ-H group), Scr and BUN contents, IgA-positive area fluorescence intensities, relative abundances of Firmicutes, Th17 cell proportions, and Th17/Treg were significantly decreased in both BQTQ-L and BQTQ-H groups (P<0.05); while the Chao1, Observed species, Shannon, and Simpson (except for BQTQ-H group) indexes, the relative abundances of Bacteroidota, and the proportions of Treg were significantly increased (P<0.05). Differential microbiota included c_Clostridia (BQTQ-L group vs. Model group) and g_Ruminococcus (BQTQ-H group vs. Model group), etc. CONCLUSIONS Buqi tongqiao formula may alleviate renal injury and exert a renal protective effect in IgAN rats by modulating intestinal flora homeostasis and Th17/Treg immune balance.
4. Research progress on status and mechanism of low sensitivity or resistance of Neisseria gonorrhoeae to cephalosporin
Dan WU ; Senlin DONG ; Qiuye ZI ; Yanqing WANG
Chinese Journal of General Practitioners 2018;17(8):651-654
Cephalosporin is still the first-line drug chosen for the treatment of gonorrhea, although it is likely to develop resistance to
5.Synthesis and antitumor activity of 13-acylmatrine derivatives
Ben FU ; Yuntao TIAN ; Li DING ; Qiuye WU ; Zhongwu GUO ; Qingjie ZHAO
Journal of Pharmaceutical Practice 2017;35(1):12-16
Objective To synthesize a series of 13-acylmatrine derivatives and evaluate their in vitro antitumor activity . Methods Using sophocarpine as the starting material ,a series of new compounds were synthesized through Michael addition , Staudinger reduction and acylation .The structure of target compounds were confirmed by 1 H NMR and MS techniques .Their antitumoractivityagainsthumanhepatomacells(BEL-7404)andmicemelanomacells(K111)wereevaluated invitrobyMTT assay .Results We synthesized 9 compounds and all the compounds exhibited inhibitory activities against BEL-7404 and K111 . Conclusion Compound 4b and compound 4e exhibit good in vitro antitumor activity to human hepatoma cells (BEL-7404) .
6.Synthesis and antifungal activity of the novel azole compounds
Xuefeng KE ; Jingzhe LI ; Ben FU ; Liangjing LI ; Xiaoyun CHAI ; Qiuye WU
Journal of Pharmaceutical Practice 2017;35(1):22-25,59
Objective To design and synthesize novel triazole antifungal derivatives with 1 ,3 ,4-oxadiazole side chain for the study of antifungal activities. Methods Fourteen title compounds were synthesized via acylation ,aminolysis reaction ,cy-clization ,nucleophilic substitution ,etc. All the compounds were characterized by 1 H NMR ,MS spectra. The in vitro antifun-gal activities were evaluated against six human pathogenic fungi through the micro-broth dilution method. Results The title compounds exhibited strong antifungal activities against all the tested fungi ,especially against Candida albicans. Compounds 10d ,10i , 10l , and 10n were found to be the most effective , with a minimum inhibitory concentration (MIC80 ) of 0.003 9 μg/ml .They are 16-fold more potent than ICZ ( MIC80 0.062 5 μg/ml) and 64-fold more potent than FCZ (MIC80 0.25 μg/ml) .Conclusion The 1 ,3 ,4-oxadiazole side chain could affect the antifungal activities. That could be due to the prop-er incorporation between the 1 ,3 ,4-oxadiazole substituted phenyl ring with the target enzyme.
7.Research progress on the selective estrogen receptor modulators
Hao DING ; Fan YANG ; Yi CAI ; Xiaoyun CHAI ; Qiuye WU
Journal of Pharmaceutical Practice 2016;(1):1-4,55
Breast cancer has become the main malignant tumors which pose a serious threat to women's health .Selective estrogen receptor modulators ,which served as the effective drug treatment ,have been attracting more attention .Present re‐search progress on the selective estrogen receptor modulators was summarized in this paper .
8.Research progress in the synthesis of tumor-associated carbohydrate antigens (TACAs) GM3 and de rivatives
Guojing BAI ; Xiaojie BIAN ; Kuo YAO ; Junqi WU ; Shichong YU ; Qingguo MENG ; Qiuye WU
Journal of Pharmaceutical Practice 2016;(1):5-7,15
Glycosylation is the key step of the synthesis of GM3 ,its reaction conditions are very harsh ,the stereoselec‐tivities are usually poor ,and the configuration of anomeric carbon is difficult to control .Whetherαglycosidic bond can be con‐structed efficiently in sialylation reactions is an important criteria used to evaluate the reaction quality .Studies of GM3 and de‐rivatives methods generally relates to following areas :the choice of the donor compounds and receptor compounds ,the control of stereoselectivity ,and the development of some new glycosidic reaction catalyst .In recent years ,important progress has been made in this research area .Now ,we predominately make a summary and review on the progress of methods for the synthesis of GM3 and derivatives .
9.Research progress in the synthesis of antigen Bacillus anthracis tetrasaccharide
Lei HUANG ; Kehan XU ; Junqi WU ; Kuo YAO ; Shichong YU ; Qiuye WU
Journal of Pharmaceutical Practice 2015;(6):481-485,569
Objective Anthrax is an anthropozoonosis caused by the bacterium Bacillus anthracis .Bacillus anthracis is an aerobic ,spore-forming ,rod-shaped bacterium ,which infects human through ingestion or inhalation of the spores .The exos-porium of spores of Bacillus anthracis contains tetrasaccharide antigen with specific chemical structure ,which can be used in preparation of glycoconjugates vaccines ,inducing an immune response .This paper reviewed articles in the last decade that re-ported research advances in chemical synthesis of anthrax tetrasaccharide ,presented the methods for synthesis ,and compared the advantages and limitations among different methods .
10.Research progress of inhibitors of peptides and peptidomimetic acting on P 53-MDM2 i nte rf ace
Xiang LI ; Yan ZOU ; Maocheng WU ; Ting HUANG ; Honggang HU ; Qiuye WU
Journal of Pharmaceutical Practice 2015;(6):494-497,512
Tumor diseases have attracted great attention of the society because of the increasing morbidity in recent years .To inhibit the P53-MDM2 interaction has become an important target for design of cancer drug ,and a lot of peptide and small molecule inhibitors have been found with various kinds of drug screening and research tools .This paper summarized the recent progress of the peptide and peptidomimetic inhibitors of P53-MDM2 at home and abroad lately .

Result Analysis
Print
Save
E-mail